Clinical trial
Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock…
NCT00417378 · Deutsches Herzzentrum Muenchen, Other · Completed
Key facts
| NCT number | NCT00417378 |
|---|---|
| Title | Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK) |
| Official title | Left Ventricular Assist Device (Impella LP 2.5) vs. Intraaortic Balloon Counterpulsation (IABP) in Patients With Cardiogenic Shock and Acute Coronary Syndromes |
| Lead sponsor | Deutsches Herzzentrum Muenchen, Other |
| Collaborators | Abiomed Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Shock, Cardiogenic, Myocardial Infarction |
| Intervention type | Device |
| Interventions | Left Ventricular Assist Device Impella LP 2.5, Intraaortic Balloon Pump |
| Enrollment | 26 |
| Start date | Aug 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Jan 1, 2007 |
| Last update posted | Nov 28, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: